chagasic patients
Differential cytokine profiling in Chagasic patients according to their arrhythmogenic status
10
Use of the Trypanosoma cruzi Recombinant Complement Regulatory Protein To Evaluate Therapeutic Efficacy following Treatment of Chronic Chagasic Patients
6
Chagasic patients are able to respond against a viral antigen from influenza virus
8
Characterising the KMP 11 and HSP 70 recombinant antigens' humoral immune response profile in chagasic patients
11
Probing Population Dynamics of Trypanosoma cruzi during Progression of the Chronic Phase in Chagasic Patients
8
New Treatments for Chagas Disease and the Relationship between Chagasic Patients and Cancers
19
Short term follow up of chagasic patients after benznidazole treatment using multiple serological markers
7
Host cell invasion and oral infection by Trypanosoma cruzi strains of genetic groups TcI and TcIV from chagasic patients
12
Anti Trypanosoma cruzi and anti laminin antibodies in chagasic patients after specific treatment
6
Trypanosoma cruzi Discret Typing Units (TcII and TcVI) in samples of patients from two municipalities of the Jequitinhonha Valley, MG, Brazil, using two molecular typing strategies
11
Anti-Trypanosoma cruzi Immunoglobulin G1 Can Be a Useful Tool for Diagnosis and Prognosis of Human Chagas' Disease
7
The C-terminal region of Trypanosoma cruzi MASPs is antigenic and secreted via exovesicles.
13
Different serological cross reactivity of Trypanosoma rangeli forms in Trypanosoma cruzi infected patients sera
10
Mapping of B-Cell Epitopes in a Trypanosoma cruzi Immunodominant Antigen Expressed in Natural Infections
5
Use of a 24 kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease
5
PCR Assay for Monitoring Trypanosoma cruzi Parasitemia in Childhood after Specific Chemotherapy
5
Serological diagnosis of Chagas' disease: a potential confirmatory assay using preserved protein antigens of Trypanosoma cruzi
6
Design, Construction, and Evaluation of a Specific Chimeric Antigen To Diagnose Chagasic Infection
7
Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy
10
Expression in Escherichia coli of a dominant immunogen of Trypanosoma cruzi recognized by human chagasic sera
6